Correlation Between Millennium Pharmacon and Integra Indocabinet

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Millennium Pharmacon and Integra Indocabinet at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Millennium Pharmacon and Integra Indocabinet into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Millennium Pharmacon International and Integra Indocabinet Tbk, you can compare the effects of market volatilities on Millennium Pharmacon and Integra Indocabinet and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Millennium Pharmacon with a short position of Integra Indocabinet. Check out your portfolio center. Please also check ongoing floating volatility patterns of Millennium Pharmacon and Integra Indocabinet.

Diversification Opportunities for Millennium Pharmacon and Integra Indocabinet

0.12
  Correlation Coefficient

Average diversification

The 3 months correlation between Millennium and Integra is 0.12. Overlapping area represents the amount of risk that can be diversified away by holding Millennium Pharmacon Internati and Integra Indocabinet Tbk in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Integra Indocabinet Tbk and Millennium Pharmacon is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Millennium Pharmacon International are associated (or correlated) with Integra Indocabinet. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Integra Indocabinet Tbk has no effect on the direction of Millennium Pharmacon i.e., Millennium Pharmacon and Integra Indocabinet go up and down completely randomly.

Pair Corralation between Millennium Pharmacon and Integra Indocabinet

Assuming the 90 days trading horizon Millennium Pharmacon International is expected to under-perform the Integra Indocabinet. But the stock apears to be less risky and, when comparing its historical volatility, Millennium Pharmacon International is 1.22 times less risky than Integra Indocabinet. The stock trades about -0.01 of its potential returns per unit of risk. The Integra Indocabinet Tbk is currently generating about 0.11 of returns per unit of risk over similar time horizon. If you would invest  23,800  in Integra Indocabinet Tbk on September 26, 2024 and sell it today you would earn a total of  6,800  from holding Integra Indocabinet Tbk or generate 28.57% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Millennium Pharmacon Internati  vs.  Integra Indocabinet Tbk

 Performance 
       Timeline  
Millennium Pharmacon 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Millennium Pharmacon International has generated negative risk-adjusted returns adding no value to investors with long positions. Despite quite persistent forward-looking signals, Millennium Pharmacon is not utilizing all of its potentials. The latest stock price mess, may contribute to short-term losses for the institutional investors.
Integra Indocabinet Tbk 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Integra Indocabinet Tbk are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. Despite quite conflicting forward-looking signals, Integra Indocabinet disclosed solid returns over the last few months and may actually be approaching a breakup point.

Millennium Pharmacon and Integra Indocabinet Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Millennium Pharmacon and Integra Indocabinet

The main advantage of trading using opposite Millennium Pharmacon and Integra Indocabinet positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Millennium Pharmacon position performs unexpectedly, Integra Indocabinet can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Integra Indocabinet will offset losses from the drop in Integra Indocabinet's long position.
The idea behind Millennium Pharmacon International and Integra Indocabinet Tbk pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.

Other Complementary Tools

Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals